In the context of BD treatment, DNA analysis of the patient and parents may be useful after the second biotinidase activity measurement if the result is approximately 30% of normal activity to gather further evidence for partial BD and consequent treatment intervention. This evidence concerns the gene BTD and Behcet disease.